Clinical studies aimed at assessing the association between lncRNA-UCA1 transcriptional regulators and pathological parameters of bladder carcinoma tissues are needed for confirming our results and for exploring the potential clinical application of lncRNA-UCA1 as a therapeutic target for bladder cancer. Here, UCA1 is linked to urinary bladder carcinoma.